Theranos Restructuring with Research Focus

The blood-testing company is shutting down clinical labs, laying off more than 300 employees across three states.

| 1 min read

Listen with Speechify

0:00

1:00

Theranos is laying off around 340 employees of clinical labs and “wellness centers” in Arizona, California, and Pennsylvania, Chief Executive Officer Elizabeth Holmes announced yesterday (October 5). This year alone, the company has been investigated by various federal agencies for allegedly misleading officials and operating a lab under substandard conditions; Holmes has been banned from running labs for two years.

In an open letter addressed to the firm’s stakeholders, Holmes yesterday said Theranos would be shifting its focus to research only.

“We will return our undivided attention to our miniLab platform,” Holmes wrote, referring to technology she debuted at the American Association for Clinical Chemistry’s annual meeting in Philadelphia this August. “Our ultimate goal is to commercialize miniaturized, automated laboratories capable of small-volume sample testing, ...

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!

Join for free today

Already a member? Login Here